blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3826536

EP3826536 - DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  24.10.2024
Database last updated on 12.11.2024
FormerRequest for examination was made
Status updated on  30.04.2021
FormerThe international publication has been made
Status updated on  01.02.2020
Most recent event   Tooltip25.10.2024First examination report 
Applicant(s)For all designated states
The Heart Research Institute Ltd
7 Eliza Street
Newtown, New South Wales 2042 / AU
[2022/31]
Former [2021/22]For all designated states
Victor Chang Cardiac Research Institute
Lowy Packer Building
405 Liverpool St
Darlinghurst NSW 2010 / AU
Inventor(s)01 / STOCKER, Roland
405 Liverpool Street
Sydney, New South Wales 2010 / AU
02 / RASHID, Imran
405 Liverpool Street
Sydney, New South Wales 2010 / AU
 [2021/22]
Representative(s)De Clercq & Partners
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
[2021/22]
Application number, filing date19841196.925.07.2019
[2021/22]
WO2019AU50788
Priority number, dateAU2018090269925.07.2018         Original published format: AU 2018902699
[2021/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020019040
Date:30.01.2020
Language:EN
[2020/05]
Type: A1 Application with search report 
No.:EP3826536
Date:02.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 30.01.2020 takes the place of the publication of the European patent application.
[2021/22]
Search report(s)International search report - published on:AU30.01.2020
(Supplementary) European search report - dispatched on:EP30.03.2022
ClassificationIPC:A61B5/055
[2022/17]
CPC:
A61B5/055 (EP,US); A61B5/05 (AU); A61B5/02007 (EP,AU,US);
A61B5/026 (EP,US); A61B5/7275 (EP,US); A61K49/0002 (AU,US);
A61K49/085 (EP,US); A61K49/10 (EP); A61K49/103 (EP);
A61K49/105 (US); G01R33/5601 (EP,AU); A61K49/06 (AU) (-)
Former IPC [2021/22]A61B5/05
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/22]
TitleGerman:NACHWEIS VON INSTABILER ATHEROSKLEROTISCHER PLAQUE MIT HOHEM RISIKO[2021/22]
English:DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE[2021/22]
French:DÉTECTION DE PLAQUE D'ATHÉROSCLÉROSE INSTABLE À HAUT RISQUE[2021/22]
Entry into regional phase23.02.2021National basic fee paid 
23.02.2021Search fee paid 
23.02.2021Designation fee(s) paid 
23.02.2021Examination fee paid 
Examination procedure23.02.2021Examination requested  [2021/22]
19.10.2022Amendment by applicant (claims and/or description)
23.10.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
30.07.2021Renewal fee patent year 03
27.07.2022Renewal fee patent year 04
26.07.2023Renewal fee patent year 05
25.07.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2005112759  (PHARMACYCLICS INC [US], et al);
 [A]WO2006014530  (GEN HOSPITAL CORP [US], et al) [A] 1-15 * page 5 line 30 - page 6 line 26 *;
 [A]US2013045161  (SIGALOV ALEXANDER B [US]) [A] 1-15 * paragraphs [0028] - [0033] *;
 [A]  - TENG, N. et al., "The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture", Redox Report, (20170403), vol. 22, no. 2, pages 51 - 73, XP055681355 [A] 1-15 * abstract, fig. 2, pages 54 and 66 *

DOI:   http://dx.doi.org/10.1080/13510002.2016.1256119
 [A]  - WILDGRUBER, M. et al., "Molecular Imaging of Inflammation in Atherosclerosis", Theranostics, (20130000), vol. 3, no. 11, pages 865 - 884, XP055681361 [A] 1-15 * abstract; fig. I and 6 *

DOI:   http://dx.doi.org/10.7150/thno.5771
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.